Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

I-Mab (IMAB) Short Interest Ratio & Short Volume

$1.74
-0.03 (-1.69%)
(As of 05/30/2024 ET)

I-Mab Short Interest Data

Current Short Interest
1,180,000 shares
Previous Short Interest
1,160,000 shares
Change Vs. Previous Month
+1.72%
Dollar Volume Sold Short
$2.15 million
Short Interest Ratio
4.8 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
80,880,000 shares
Percentage of Shares Shorted
1.46%
Today's Trading Volume
48,579 shares
Average Trading Volume
384,308 shares
Today's Volume Vs. Average
13%
Skip Charts & View Short Interest History

IMAB Short Interest Over Time

IMAB Days to Cover Over Time

IMAB Percentage of Float Shorted Over Time

I-Mab Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20241,180,000 shares $2.15 million +1.7%N/A4.8 $1.82
4/30/20241,160,000 shares $2.05 million -10.8%N/A3.6 $1.77
4/15/20241,300,000 shares $2.34 million +11.1%N/A3.4 $1.80
3/31/20241,170,000 shares $2.18 million +7.3%N/A2.7 $1.86
3/15/20241,090,000 shares $2.03 million +1.9%N/A2 $1.86
2/29/20241,070,000 shares $1.90 million -5.3%N/A1.9 $1.78
Nvidia is about to pass Apple (Ad)

A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”

Click here to find out who they are.
2/15/20241,130,000 shares $2.00 million -28.0%N/A2 $1.77
1/31/20241,570,000 shares $2.78 million +4.0%N/A2.6 $1.77
1/15/20241,510,000 shares $3.10 million -6.8%N/A2.4 $2.05
12/31/20231,620,000 shares $3.08 million -11.5%N/A2.5 $1.90
12/15/20231,830,000 shares $2.54 million -1.6%N/A3.1 $1.39
11/30/20231,860,000 shares $2.90 million -2.6%N/A2.7 $1.56
11/15/20231,910,000 shares $3.29 million No ChangeN/A2.5 $1.72
10/31/20231,910,000 shares $2.73 million +26.5%N/A2.4 $1.43
10/15/20231,510,000 shares $2.02 million +11.0%N/A2.2 $1.34
9/30/20231,360,000 shares $1.80 million -25.3%N/A2.1 $1.32
9/15/20231,820,000 shares $2.44 million +11.7%N/A3 $1.34
8/31/20231,630,000 shares $3.10 million -0.6%N/A3.5 $1.90
8/15/20231,640,000 shares $3.92 million +7.9%N/A4.8 $2.39
7/31/20231,520,000 shares $4.38 million -4.4%N/A5 $2.88
7/15/20231,590,000 shares $4.44 million +3.9%N/A5.3 $2.79
6/30/20231,530,000 shares $4.57 million -1.9%N/A5.4 $2.99
6/15/20231,560,000 shares $4.80 million +0.7%N/A4.6 $3.08
5/31/20231,550,000 shares $4.81 million -5.5%N/A4.5 $3.10
5/15/20231,640,000 shares $5.33 million -13.7%N/A4.7 $3.25
4/30/20231,900,000 shares $5.85 million -5.9%N/A5.1 $3.08
4/15/20232,020,000 shares $7.11 million +8.6%N/A5.1 $3.52
3/31/20231,860,000 shares $6.44 million +10.1%N/A3.9 $3.46
3/15/20231,690,000 shares $6.54 million -7.1%N/A2.9 $3.87
2/28/20231,820,000 shares $7.83 million -6.7%N/A3.1 $4.30
2/15/20231,950,000 shares $8.89 million -16.7%N/A3.3 $4.56
1/31/20232,340,000 shares $14.09 million +13.0%N/A3.9 $6.02
1/15/20232,070,000 shares $15.30 million +9.5%N/A3.7 $7.39
12/30/20221,890,000 shares $7.90 million -3.1%N/A3.4 $4.18
12/15/20221,950,000 shares $7.29 million +3.7%N/A4.7 $3.74
11/30/20221,880,000 shares $6.96 million -11.7%N/A4.2 $3.70
11/15/20222,130,000 shares $10.35 million +2.9%N/A4.2 $4.86
10/31/20222,070,000 shares $7.68 million -5.9%N/A3.3 $3.71
10/15/20222,200,000 shares $8.21 million -22.8%N/A3.2 $3.73
9/30/20222,850,000 shares $11.43 million +9.2%N/A4.4 $4.01
Nvidia is about to pass Apple (Ad)

A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”

Click here to find out who they are.
9/15/20222,610,000 shares $14.15 million -2.3%N/A4 $5.42
8/31/20222,670,000 shares $16.37 million -2.9%N/A3.9 $6.13
8/15/20222,750,000 shares $21.92 million -6.8%N/A3.2 $7.97
7/31/20222,950,000 shares $30.92 million -15.0%N/A3.4 $10.48
7/15/20223,470,000 shares $31.06 million +11.9%N/A3.7 $8.95
6/30/20223,100,000 shares $35.03 million +1.6%N/A2.6 $11.30
6/15/20223,050,000 shares $29.86 million -13.4%N/A2.3 $9.79
5/31/20223,520,000 shares $30.62 million -9.3%N/A2.4 $8.70
5/15/20223,880,000 shares $46.56 million -4.4%N/A3 $12.00
4/30/20224,060,000 shares $50.91 million +8.9%N/A3.2 $12.54
4/15/20223,730,000 shares $49.68 million -3.4%N/A2.9 $13.32
3/31/20223,860,000 shares $62.69 million -8.8%N/A3.7 $16.24
3/15/20224,230,000 shares $57.02 million +6.6%N/A4.9 $13.48
2/28/20223,970,000 shares $98.14 million +5.0%N/A5.4 $24.72
2/15/20223,780,000 shares $105.16 million +14.2%N/A5.5 $27.82
1/31/20223,310,000 shares $83.58 million +18.6%N/A5.3 $25.25
1/15/20222,790,000 shares $97.82 million -18.9%N/A0 $35.06
12/31/20213,440,000 shares $163.02 million +31.3%N/A7.4 $47.39
12/15/20212,620,000 shares $123.06 million -0.4%N/A5.3 $46.97
11/30/20212,630,000 shares $159.01 million -1.9%N/A5.3 $60.46
11/15/20212,680,000 shares $162.92 million +7.6%N/A5.2 $60.79
10/29/20212,490,000 shares $153.86 million -1.2%N/A4.5 $61.79
10/15/20212,520,000 shares $165.89 million +18.9%N/A4 $65.83
9/30/20212,120,000 shares $153.68 million +6.5%N/A3.2 $72.49
9/15/20211,990,000 shares $135.56 million +8.7%N/A3.2 $68.12
8/31/20211,830,000 shares $129.78 million -4.7%2.6%3.1 $70.92
8/13/20211,920,000 shares $134.75 million -8.6%2.6%2.9 $70.18
7/30/20212,100,000 shares $163.97 million +18.0%2.8%3 $78.08
7/15/20211,780,000 shares $132.00 million -16.8%N/A2.9 $74.16
6/30/20212,140,000 shares $179.65 million -0.9%N/A3.6 $83.95
6/15/20212,160,000 shares $151.93 million +9.1%N/A3.8 $70.34
5/28/20211,980,000 shares $160.52 million +39.4%N/A3.6 $81.07
5/14/20211,420,000 shares $88.15 million +2.2%N/A3.1 $62.08
4/30/20211,390,000 shares $83.40 million -11.5%N/A3.4 $60.00
4/15/20211,570,000 shares $86.49 million +52.4%N/A4.2 $55.09
3/31/20211,030,000 shares $48.59 million +46.3%N/A2.9 $47.17
3/15/2021704,000 shares $38.73 million +21.8%N/A2.1 $55.01
2/26/2021578,000 shares $33.80 million -19.0%N/A1.8 $58.48
2/12/2021713,300 shares $41.00 million -8.9%N/A2.6 $57.48
1/29/2021782,800 shares $40.91 million -9.4%N/A2.9 $52.26
1/15/2021864,100 shares $43.00 million No ChangeN/A3.3 $49.76

IMAB Short Interest - Frequently Asked Questions

What is I-Mab's current short interest?

Short interest is the volume of I-Mab shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 1,180,000 shares of IMAB short. Learn More on I-Mab's current short interest.

What is a good short interest ratio for I-Mab?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMAB shares currently have a short interest ratio of 5.0. Learn More on I-Mab's short interest ratio.

Is I-Mab's short interest increasing or decreasing?

I-Mab saw a increase in short interest in May. As of May 15th, there was short interest totaling 1,180,000 shares, an increase of 1.7% from the previous total of 1,160,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does I-Mab's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to I-Mab: Cryoport, Inc. (8.54%), Avid Bioservices, Inc. (18.68%), IGM Biosciences, Inc. (24.78%), Entrada Therapeutics, Inc. (9.08%), SIGA Technologies, Inc. (12.36%), Y-mAbs Therapeutics, Inc. (9.85%), Olema Pharmaceuticals, Inc. (15.27%), Travere Therapeutics, Inc. (17.65%), Heron Therapeutics, Inc. (20.09%), COMPASS Pathways plc (5.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short I-Mab stock?

Short selling IMAB is an investing strategy that aims to generate trading profit from I-Mab as its price is falling. IMAB shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against I-Mab?

A short squeeze for I-Mab occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMAB, which in turn drives the price of the stock up even further.

How often is I-Mab's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMAB, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:IMAB) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners